Clinical Trials
- Heart/Cardiovascular
Double blind randomized autologous stem cell trial treatment for peripheral arterial disease (PAD) with critical limb threatening ischemia
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
The Access 2 Trial
- Ages65 years and older
- GenderBoth